Emma Walmsley, GSK CEO
Exclusive: GSK CEO Emma Walmsley talks about vaccines, M&A and the company’s future
British drug giant GSK is at an inflection point. The company shed its consumer unit Haleon and plans to put the proceeds into building out …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
